中文English
ISSN 1001-5256 (Print)
ISSN 2097-3497 (Online)
CN 22-1108/R
Volume 39 Issue 4
Apr.  2023
Turn off MathJax
Article Contents

Value of spleen volume in predicting portal hypertensive gastropathy and its severity in patients with liver cirrhosis

DOI: 10.3969/j.issn.1001-5256.2023.04.013
Research funding:

Hubei Provincial Natural Science Foundation Project (2018CFB619)

More Information
  • Corresponding author: CHEN Wei, chenweiyf@163.com (ORCID: 0000-0002-6985-4595)
  • Received Date: 2022-09-17
  • Accepted Date: 2022-10-20
  • Published Date: 2023-04-20
  •   Objective  To investigate the value of spleen volume (SV) in predicting portal hypertensive gastropathy (PHG) and severe PHG in patients with liver cirrhosis.  Methods  A retrospective analysis was performed for the clinical data of 168 patients with liver cirrhosis who were admitted to Xiangyang No.1 People's Hospistal Affiliated to Hubei University of Medicine from January 2018 to August 2022, and with the results of gastroscopy as the gold standard, these patients were divided into non-PHG group with 115 patients and PHG group with 53 patients; the PHG group was further divided into mild PHG group with 26 patients and severe PHG group with 27 patients. All patients underwent electronic gastroscopy, abdominal magnetic resonance imaging, and serological examination to obtain related indices and parameters. The group t-test was used for comparison of normally distributed continuous data between two groups, and the Mann-Whitney U test was used for comparison of non-normally distributed continuous data between two groups; the chi-square test was used for comparison of categorical data between two groups. A multivariate Logistic regression analysis was used to screen out the independent risk factors for PHG and severe PHG, and the receiver operating characteristic (ROC) curve was used to compare the predictive value of related indices or parameters. The area under the Roccurve is compared using Delong test.  Results  The univariate analysis showed that there were significant differences between the PHG group and the non-PHG group in sex, presence or absence of ascites, hemoglobin (Hb), platelet count (PLT), aspartate aminotransferase, total bilirubin, albumin (Alb), prothrombin time, international normalized ratio, Child-Pugh class, FIB-4 score, King score, Lok score, spleen diameter (SD), SV, platelet count/spleen diameter ratio (PSDR), and platelet count/spleen volume ratio (PSVR) (all P < 0.05), and there were significant differences in Hb, PLT, Alb, SD, SV, PSDR, and PSVR between the mild PHG group and the severe PHG group (all P < 0.05). The multivariate Logistic regression analysis showed that FIB-4 score (odds ratio [OR]=1.280, 95% confidence interval [CI]: 1.009-1.625, P < 0.05) and SV (OR=1.007, 95% CI: 1.001-1.013, P < 0.05) were independent risk factors for PHG, and SV (OR=0.990, 95% CI: 0.980-1.000, P < 0.05) was an independent influencing factor for severe PHG. The ROC curve analysis showed that in predicting PHG, SV had a larger area under the ROC curve (AUC) than FIB-4 score (0.884 vs 0.825, P < 0.05), with a sensitivity of 0.774 and a specificity of 0.870 at the optimal cut-off value of 406.82; in predicting the onset of severe PHG, SV had an AUC of 0.782, with a sensitivity of 0.593 and a specificity of 0.962 at the optimal cut-off value of 714.63.  Conclusion  SV has a good value in predicting the onset of PHG and severe PHG.

     

  • loading
  • [1]
    LIU XJ, CHEN MK. Research advances in portal hypertensive gastropathy[J]. Chin J Dig Endosc, 2020, 37(10): 762-765. DOI: 10.3760/cma.j.cn321463-20191014-00688.

    刘小娇, 陈明锴. 门脉高压性胃病研究进展[J]. 中华消化内镜杂志, 2020, 37(10): 762-765. DOI: 10.3760/cma.j.cn321463-20191014-00688.
    [2]
    ROCKEY DC. An update: Portal hypertensive gastropathy and colopathy[J]. Clin Liver Dis, 2019, 23(4): 643-658. DOI: 10.1016/j.cld.2019.07.002.
    [3]
    LYLES T, ELLIOTT A, ROCKEY DC. A risk scoring system to predict in-hospital mortality in patients with cirrhosis presenting with upper gastrointestinal bleeding[J]. J Clin Gastroenterol, 2014, 48(8): 712-720. DOI: 10.1097/MCG.0000000000000014.
    [4]
    WANG WS, CHEN DF, WEN LZ. Highlights in portal hypertensive gastropathy[J]. J Prac Hepatol, 2019, 22(4): 601-604. DOI: 10.3969/j.issn.1672-5069.2019.04.038.

    王文生, 陈东风, 文良志. 门脉高压性胃病临床研究进展[J]. 实用肝脏病杂志, 2019, 22(4): 601-604. DOI: 10.3969/j.issn.1672-5069.2019.04.038.
    [5]
    AMER IF, EL SHENNAWY EM, EL BATEA H, et al. Accuracy of noninvasive tests in the prediction of portal hypertensive gastropathy in Egyptian patients with cirrhosis[J]. JGH Open, 2021, 5(2): 286-293. DOI: 10.1002/jgh3.12486.
    [6]
    EL-KALLA F, MANSOUR L, KOBTAN A, et al. Blood ammonia level correlates with severity of cirrhotic portal hypertensive gastropathy[J]. Gastroenterol Res Pract, 2018, 2018: 9067583. DOI: 10.1155/2018/9067583.
    [7]
    NISHINO K, KAWANAKA M, MANABE N, et al. Portal hypertensive gastropathy in liver cirrhosis: Prevalence, natural history, and risk factors[J]. Intern Med, 2022, 61(5): 605-613. DOI: 10.2169/internalmedicine.7943-21.
    [8]
    MIN YW, BAE SY, GWAK GY, et al. A clinical predictor of varices and portal hypertensive gastropathy in patients with chronic liver disease[J]. Clin Mol Hepatol, 2012, 18(2): 178-184. DOI: 10.3350/cmh.2012.18.2.178.
    [9]
    YU S, CHEN W, JIANG Z. Platelet count/spleen volume ratio has a good predictive value for esophageal varices in patients with hepatitis B liver cirrhosis[J]. PLoS One, 2021, 16(12): e0260774. DOI: 10.1371/journal.pone.0260774.
    [10]
    Chinese Society of Hepatology, Chinese Medical Association. Chinese guidelines on the management of liver cirrhosis[J]. J Clin Hepatol, 2019, 35(11): 2408-2425. DOI: 10.3969/j.issn.1001-5256.2019.11.006.

    中华医学会肝病学分会. 肝硬化诊治指南[J]. 临床肝胆病杂志, 2019, 35(11): 2408-2425. DOI: 10.3969/j.issn.1001-5256.2019.11.006.
    [11]
    DE FRANCHIS R. Updating consensus in portal hypertension: report of the Baveno Ⅲ Consensus Workshop on definitions, methodology and therapeutic strategies in portal hypertension[J]. J Hepatol, 2000, 33(5): 846-852. DOI: 10.1016/s0168-8278(00)80320-7.
    [12]
    BADRAN DH, KALBOUNEH HM, AL-HADIDI MT, et al. Ultrasonographic assessment of splenic volume and its correlation with body parameters in a Jordanian population[J]. Saudi Med J, 2015, 36(8): 967-972. DOI: 10.15537/smj.2015.8.11809.
    [13]
    MOROZOV SV, IZRANOV VA. Methods of ultrasound spleen morphometry[J]. J Ultrasound Med, 2022, 41(9): 2123-2133. DOI: 10.1002/jum.15901.
    [14]
    LI Y, WANG ZH, LI PP, et al. 3D visualization technology for measuring the spleen volume of normal Chinese adult[J]. J Hepatobiliary Surg, 2018, 26(5): 340-343. DOI: 10.3969/j.issn.1006-4761.2018.05.007.

    李曜, 王志恒, 李鹏鹏, 等. 三维可视化技术测定中国正常成人脾脏体积的研究[J]. 肝胆外科杂志, 2018, 26(5): 340-343. DOI: 10.3969/j.issn.1006-4761.2018.05.007.
    [15]
    DE FRANCHIS R. Evolving consensus in portal hypertension. Report of the Baveno Ⅳ consensus workshop on methodology of diagnosis and therapy in portal hypertension[J]. J Hepatol, 2005, 43(1): 167-176. DOI: 10.1016/j.jhep.2005.05.009.
    [16]
    CHEN SY, LIN QY, HUANG XQ. Studies on diagnosis and pathogenesis of portal hypertensive gastropathy[J]. J Diagn Concepts Pract, 2016, 15(5): 451-454. DOI: 10.16150/j.1671-2870.2016.05.003.

    陈世耀, 林秋燕, 黄晓铨. 门静脉高压性胃病的诊断及发病机制研究[J]. 诊断学理论与实践, 2016, 15(5): 451-454. DOI: 10.16150/j.1671-2870.2016.05.003.
    [17]
    DE FRANCHIS R, BOSCH J, GARCIA-TSAO G, et al. Baveno Ⅶ-Renewing consensus in portal hypertension[J]. J Hepatol, 2022, 76(4): 959-974. DOI: 10.1016/j.jhep.2021.12.022.
    [18]
    SALEEM K, BAIG FA, NIDA M, et al. Correlation between severity of portal hypertensive gastropathy and size of oesophageal varices in cirrhotic hepatitis-C patients[J]. J Ayub Med Coll Abbottabad, 2018, 30(1): 54-57.
    [19]
    SIMBRUNNER B, BEER A, WÖRAN K, et al. Portal hypertensive gastropathy is associated with iron deficiency anemia[J]. Wien Klin Wochenschr, 2020, 132(1-2): 1-11. DOI: 10.1007/s00508-019-01593-w.
    [20]
    SUN DY. Prediction of FIB-4、Lok and King score measurement for esophageal varices in cirrhosis[D]. Hefei: Anhui Medical University, 2021.

    孙迪一. FIB-4、Lok和King评分对肝硬化食管静脉曲张的预测价值[D]. 合肥: 安徽医科大学, 2021.
    [21]
    MANDHWANI R, HANIF FM, UL HAQUE MM, et al. Noninvasive clinical predictors of portal hypertensive gastropathy in patients with liver cirrhosis[J]. J Transl Int Med, 2017, 5(3): 169-173. DOI: 10.1515/jtim-2017-0025.
    [22]
    JIANG A, LI ZF. Common causes and treatment strategies of hyperslenism[J/OL]. Chin J Hepat Surg (Electronic Edition), 2018, 7(2): 97-99. DOI: 10.3877/cma.j.issn.2095-3232.2018.02.003.

    蒋安, 李宗芳. 脾功能亢进常见原因及治疗策略[J/OL]. 中华肝脏外科手术学电子杂志, 2018, 7(2): 97-99. DOI: 10.3877/cma.j.issn.2095-3232.2018.02.003.
  • 加载中

Catalog

    通讯作者: 陈斌, bchen63@163.com
    • 1. 

      沈阳化工大学材料科学与工程学院 沈阳 110142

    1. 本站搜索
    2. 百度学术搜索
    3. 万方数据库搜索
    4. CNKI搜索

    Figures(2)  / Tables(5)

    Article Metrics

    Article views (355) PDF downloads(50) Cited by()
    Proportional views
    Related

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return